Assessment of the inhibitory potential of tenofovir ester conjugates against α-glucosidase activity using in-vitro and in-silico methods
Pakistan Journal of Pharmaceutical Sciences · 01.02.2027
DOI: 10.36721/pjps/2026.40.15688.1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pakistan Journal of Pharmaceutical Sciences, online erschienen am 19.10.2026. Verfasst von Aaminat Qureshi. Die Arbeit nennt 37 Literaturangaben.
Abstract (Originalsprache)
Background
Alpha-glucosidase is an essential enzyme in carbohydrate metabolism, responsible for hydrolyzing disaccharides into monosaccharides (glucose). Inhibition of this enzyme is an effective approach to control postprandial hyperglycemia in type 2 diabetes. Previous studies have reported that some antiviral agents, including tenofovir, exhibit potent α-glucosidase inhibitory activity comparable to that of acarbose.
Objectives
This study employed both in-vitro and in-silico methods to design, synthesize and assess new tenofovir ester conjugates as potential α-glucosidase inhibitors.
Method
In this study, 22 ester derivatives of tenofovir were synthesized by masking the hydroxyl group with hydroxyl, amino and phenolic groups, as well as with fatty acid chains. The synthesized compounds were thoroughly characterized using mass spectrometry, ¹H-NMR, ¹³C-NMR, NOESY, COSY, HSQC, HMBC, UV and IR spectroscopy. To assess in-vitro α-glucosidase activity, an enzyme from yeast (Saccharomyces cerevisiae) was used.
Results
All synthesized derivatives (2–22) demonstrated significant α-glucosidase inhibition, with IC50 values ranging from 7.80 ± 0.42 to 342.59 ± 2.19 µM, exhibiting greater potency than the standard inhibitor acarbose (IC50 = 875.75 ± 2.09 µM). Molecular docking studies supported these findings, showing binding energies ranging from −9.1 to −11.7 kcal/mol, greater than those achieved with acarbose (−8.4 kcal/mol). Among them, compounds 2 and 6 displayed the highest inhibitory activities (IC50 = 10.50 ± 0.46 µM and 7.80 ± 0.42 µM, respectively) with strong binding affinities (−11.5 and −11.7 kcal/mol).
Conclusion
The findings suggest that tenofovir-derived ester compounds, particularly 2 and 6, are promising candidates for the continued development of potent α-glucosidase inhibitors for the management of type 2 diabetes.
Zitieren
APA
Qureshi, A. (2027). Assessment of the inhibitory potential of tenofovir ester conjugates against α-glucosidase activity using in-vitro and in-silico methods. Pakistan Journal of Pharmaceutical Sciences. https://doi.org/10.36721/pjps/2026.40.15688.1
Vancouver
Qureshi A. Assessment of the inhibitory potential of tenofovir ester conjugates against α-glucosidase activity using in-vitro and in-silico methods. Pakistan Journal of Pharmaceutical Sciences. 2027. doi:10.36721/pjps/2026.40.15688.1
BibTeX
@article{Qureshi2027,
author = {Qureshi, Aaminat},
title = {Assessment of the inhibitory potential of tenofovir ester conjugates against α-glucosidase activity using in-vitro and in-silico methods},
journal = {Pakistan Journal of Pharmaceutical Sciences},
year = {2027},
doi = {10.36721/pjps/2026.40.15688.1}
}
EUVIMED